This page shows the latest Lexapro news and features for those working in and with pharma, biotech and healthcare.
protection for Abilify and former blockbuster antidepressant Lexapro/Celexa (escitalopram).
which it hopes will restore growth after the loss of patent protection on US blockbuster antidepressant Lexapro/Celexa (escitalopram).
its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
The antidepressant sales dropped another 33% in the third quarter
Lundbeck has high hopes for Selincro as it tries to overcome the impact of the loss of patent protection for its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate).
The first EU launch of Brintellix is another important step for the Danish company as it recovers from the loss of patent protection for its antidepressant Lexapro (escitalopram oxalate), a former ... Clinical trial results suggest Brintellix is at least
More from news
Approximately 2 fully matching, plus 30 partially matching documents found.
s best selling depression drug Lexapro and another patent cliff looming for Nameda, its Alzheimer's drug in 2015.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...